Daily Archives: Oct 6, 2025
Tan Xuguang: Enter South Korea, Full Focus on Business in the...
SEOUL, South Korea, June 16, 2024 /PRNewswire/ -- In alignment with the global strategic development of Shandong Heavy Industry, with a focus on bolstering "doorstep" export business, from June 14th to 16th, Tan Xuguang led a delegation to South Korea to conduct a thorough market survey. The visit included in-depth...
Roche’s Phase III STARGLO study demonstrates Columvi significantly extends survival in...
The study met its primary endpoint of overall survival with a 41% reduction in the risk of death in people with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with Columvi plus chemotherapy1 This Columvi combination could provide a much-needed off-the-shelf treatment option for people with transplant-ineligible...
Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat...
– ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for Non-Transfusion-Dependent Alpha- and Beta-Thalassemia – – Additional ENERGIZE Poster Presentation Highlights Improvements in Fatigue and Exercise Capacity in Patients Treated with Mitapivat Compared to Placebo – – Agios to Webcast Virtual Investor Event on...